Efficacy of lipid profiles in prediction of coronary disease☆
References (20)
- et al.
Fifteen-year mortality in coronary drug project patients: long-term benefit with niacin
J Am Coll Cardiol
(1986) - et al.
Coronary heart disease is not preventable by population interventions
Lancet
(1988) Lowering blood cholesterol to prevent heart disease
JAMA
(1985)Report of the National Cholesterol Education Program Expert Panel on detection, evaluation and treatment of high blood cholesterol in adults
Arch Int Med
(1988)Treatment of hypertriglyceridemia
JAMA
(1984)The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in the incidence of coronary heart disease
JAMA
(1984)- et al.
Helsinki Heart Study Primary Prevention Trial with gemfibrozil in middle-aged men with dyslipidemia
N Engl J Med
(1987) - et al.
Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous by-pass grafts
JAMA
(1987) - et al.
Effects of therapy with Cholestyramine on progression of coronary atherosclerosis. Results of the NHLBI Type II Coronary Intervention Study
Circulation
(1984) - et al.
Regression of coronary artery disease as a result of apolipoprotein B
N Engl J Med
(1990)
There are more references available in the full text version of this article.
Cited by (0)
- ☆
Supported by The National Heart, Lung and Blood Institute Grant numbers NIH-N01-HV-92922 and NIH-N01-HV-52971; The Charles A. Dana Foundation; Merck, Sharp and Dohme; Pfizer, and Imperial Chemical Industries.
Copyright © 1992 Published by Mosby, Inc.